Tenfold therapeutic dosing errors in young children reported to U.S. poison control centers.
OBJECTIVE
Tenfold dosing medication errors reported to U.S. poison control centers in children younger than six years of age were evaluated.


METHODS
A retrospective review of all exposures in children younger than six years of age reported to the American Association of Poison Control Centers' data collection system during 2000-04 was conducted. Cases were selected for inclusion if the exposure was an unintentional therapeutic error and if 10-fold dosing error was coded as one of the therapeutic-error scenarios. The specific substance or drug category, patient age and sex, site of exposure, clinical effects, disposition, and outcome were evaluated


RESULTS
A total of 3894 10-fold dosing errors involving a single substance in children younger than six years of age were reported over a five-year period. The site of exposure was most commonly a residence (n = 3609, 92.7%), followed by a health care facility (n = 223, 5.7%) and a school (n = 32, 0.8%). More than half of the exposures occurred in children 12 months of age or younger. When stratified by age, histamine H(2)- receptor antagonists and metoclopramide were the most common medications involved in exposures in children 12 months of age and younger. Cough and cold preparations and antibiotics were the most commonly involved medications in therapeutic errors in children over age 12 months.


CONCLUSIONS
The most common substances involved in 10-fold medication errors reported to U.S. poison control centers were histamine H(2)-receptor antagonists and metoclopramide. Most exposures occurred in the home and involved children 12 months of age or younger.
Crouch
Barbara Insley
BI
Department of Pharmacotherapy, College of Pharmacy, University of Utah, 585 Komas Drive, Suite 200, Salt Lake City, UT 84108, USA. barbara.crouch@hsc.utah.edu
Caravati
E Martin
EM
Moltz
Ed
E
D016907:Adverse Drug Reaction Reporting Systems / Q000639:trends*; D002675:Child, Preschool; D005260:Female; D006633:Histamine Antagonists / Q000009:adverse effects; D006801:Humans; D007223:Infant; D008297:Male; D008508:Medication Errors / Q000009:adverse effects* / Q000639:trends*; D008787:Metoclopramide / Q000009:adverse effects; D011039:Poison Control Centers / Q000639:trends*; D012189:Retrospective Studies; D014481:United States
D006633:Histamine Antagonists; D008787:Metoclopramide